Pfizer urged to wait until November to seek vaccine authorisation

More than 60 leading researchers said Pfizer’s clinical trial shouldn’t be rushed as it needed to monitor participants for at least two months after they received the second dose.

Leave a Reply

Your email address will not be published. Required fields are marked *